泰禾股份 reported revenue of ¥2.97B for the period ended 2026-06-30, +23.2% year on year. Net income was ¥0.30B, a 10.1% net margin on a 26.7% gross margin. The largest revenue line is 杀菌剂 at 39% of the total. Free cash flow for the period was ¥0.14B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥2.97B | +23.2% |
| Gross profit | ¥0.79B | — |
| Operating income | ¥0.37B | — |
| Net income | ¥0.30B | +20.0% |
| Gross margin | 26.7% | Net margin 10.1% |
| Revenue Q/Q | +15.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| 杀菌剂 | ¥1.17B | 39.5% |
| 除草剂 | ¥1.01B | 34.1% |
| 其他 | ¥0.47B | 15.7% |
| 功能化学品 | ¥0.32B | 10.8% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥2.18B | 73.3% |
| R&D | ¥0.09B | 3.2% |
| SG&A | ¥0.24B | 8.0% |
| Tax & other | ¥0.07B | 2.3% |
| Item | Amount |
|---|---|
| Total assets | ¥6.50B |
| Total liabilities | ¥2.24B |
| Shareholders' equity | ¥4.26B |
| Equity / assets | 65.6% |
| Operating cash flow | ¥0.26B |
| Capital expenditure | ¥0.12B |
| Free cash flow | ¥0.14B |
| Cash conversion (OCF / net income) | 181% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
大普微-UW ・ 纳百川 ・ 昊创瑞通 ・ 高特电子 ・ 欣兴工具 ・ 新恒汇 ・ 固德电材 ・ 宏明电子 ・ 慧谷新材 ・ 新广益 ・ 三瑞智能 ・ N展芯股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies